Suprane and Diprivan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Suprane (desflurane) and Diprivan (propofol). Common drug interactions include hypokalaemia among females and cardiac arrest among males.
The phase IV clinical study analyzes what interactions people have when they take Suprane and Diprivan. It is created by eHealthMe based on reports of 97 people who take the same drugs from the FDA, and is updated regularly.
What is Suprane?
Suprane has active ingredients of desflurane. eHealthMe is studying from 1,000 Suprane users. Check the latest studies of Suprane.
What is Diprivan?
Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
97 people who take Suprane and Diprivan together, and have interactions are studied.

What are the common drug interactions of Suprane and Diprivan, by gender? *:
female:
- Hypokalaemia (low potassium)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Pyrexia (fever)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Acute pulmonary oedema (sudden deposit of fluid in the lung))
- Hypoxia (low oxygen in tissues)
- Ageusia (loss of taste functions of the tongue)
- Anosmia (partial or complete loss of the sense of smell)
- Blood creatine phosphokinase increased
- Blood potassium decreased
male:
- Cardiac arrest
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Septic shock (shock due to blood infection)
- Weight decreased
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Acute respiratory distress syndrome
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood creatine phosphokinase increased
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
What are the common drug interactions of Suprane and Diprivan, by age (0-1 to 60+)? *:
0-1:
- Alanine aminotransferase increased
- Blood creatine phosphokinase increased
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Coagulation factor decreased (less clotting substance in blood)
- Cytolytic hepatitis (dissolution or destruction of a liver cell)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Haematemesis (vomiting of blood)
- Hypertension (high blood pressure)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Pyrexia (fever)
2-9:
n/a
10-19:
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
- Alveolitis (inflammation in the socket of a tooth)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hypoxia (low oxygen in tissues)
- Respiratory distress (difficulty in breathing)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Blood pressure decreased
20-29:
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
- Hypotension (abnormally low blood pressure)
- Angioedema (rapid swelling of the dermis)
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Drug hypersensitivity
- Dyspnoea (difficult or laboured respiration)
30-39:
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
- Hepatitis (inflammation of the liver)
- Asthenia (weakness)
- Blood bilirubin increased
- Eosinophil count increased
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Nausea (feeling of having an urge to vomit)
- Urine discolouration
- Urticaria (rash of round, red welts on the skin that itch intensely)
40-49:
- Renal failure (kidney dysfunction)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Hepatitis (inflammation of the liver)
- Transaminases increased
- Cardiac arrest
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Erythema (redness of the skin)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
50-59:
- Cardiac arrest
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Anaesthetic complication
- Blood pressure increased
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Postictal paralysis
- Restlessness (not able to rest)
60+:
- Cytolytic hepatitis (dissolution or destruction of a liver cell)
- Hypotension (abnormally low blood pressure)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Electrocardiogram qt prolonged
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Loss of consciousness
- Malaise (a feeling of general discomfort or uneasiness)
- Pneumonia
- Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
What are the existing conditions these people have? *
- Anaesthesia: 30 people, 30.93%
- General Anaesthesia: 19 people, 19.59%
- Pain: 9 people, 9.28%
- High Blood Pressure: 5 people, 5.15%
* Approximation only. Some reports may have incomplete information.
Do you take Suprane and Diprivan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Suprane and Diprivan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Suprane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Diprivan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Suprane and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Diprivan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on desflurane and propofol (the active ingredients of Suprane and Diprivan, respectively), and Suprane and Diprivan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Meclizine cause Venous Thrombosis? - 32 seconds ago
- Sertraline and Speech Impairment (Adult) for Men aged 50-59 - 39 seconds ago
- Sertraline and Slurred Speech for Men aged 50-59 - 39 seconds ago
- Sertraline and Language Impairment for Men aged 50-59 - 39 seconds ago
- Sertraline and Inability To Speak for Men aged 50-59 - 40 seconds ago
- Sertraline and Impairment Of Speech for Men aged 50-59 - 40 seconds ago
- Sertraline and Dysphasia for Men aged 50-59 - 40 seconds ago
- Sertraline and Dysarthria for Men aged 50-59 - 41 seconds ago
- Sertraline and Aphasia for Men aged 50-59 - 41 seconds ago
- Could Levothyroxine Sodium cause Gallbladder Disease? - 53 seconds ago